Ming Jiang

I had trained as a postdoctoral associate in Professor Pierre Chambon's Lab at IGBMC in France from 1999 to 2002, focusing on dissection of nuclear receptor RXRs and PPARs signaling pathways in the development and carcinogenesis in prostate, adipocyte, liver, and skin tissues and organs by an originally established inducible conditional Cre-ERT2/LoxP transgenic mouse model. I moved to Dr. Simon Hayward's Lab in Vanderbilt Prostate Cancer Center at Vanderbilt University Medical Center (VUMC), Nashville, TN, USA in 11/2002. I was promoted as a Research Assistant Professor of Urological Surgery in 2/2007 and then a Research Associate Professor of Medicine at VUMC in 1/2015. I am a biomedical research scientist special in cancer biopathology and translational medicine with extensive skills in establishment and characterization of primary culture cells, immortalized cell lines, 3D-organoid culture, patient-derived xenografting (PDX), and tissue recombination-xenografting (TRX) models in prostate, bladder, colorectal, and lung organs. I am currently as a Research Assistant Professor in Bayer/Harris Lab in Vanderbilt Center for Kidney Disease (VCKD) at VUMC. I am working on translational prevention and therapeutic research projects on kidney diseases, focusing on understanding mechanisms underlying the pathogenesis of both acute and chronic kidney disease, specifically in understanding the roles of COX-2 and prostaglandins in the kidney, and investigating the potential functions of innate and acquired immunity in the kidney in mediating recovery from acute injury or development of fibrosis.